http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-701665-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7016 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-074 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 |
filingDate | 2013-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70f579d43912a00c38f3534d2cfb7773 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_949b8c4f6904ec84b83bec0553be70eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12e5588b12bc6bed2bd016d2261dd651 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f7f1b9b3c8c2ce227e64fc5a8c22a90 |
publicationDate | 2016-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | NZ-701665-A |
titleOfInvention | Trehalose-containing mammalian cell suspension for prevention of pulmonary embolism formation |
abstract | This invention addresses the problem of providing: a mammalian cell suspension capable of preventing the formation of pulmonary embolisms when mammalian stem cells or other mammalian cells are administered intravenously; or a prophylactic agent against the formation of pulmonary embolisms when mammalian cells are administered intravenously. This invention is characterized by the suspension of mammalian stem cells or other mammalian cells in a physiological aqueous solution including as an effective component thereof trehalose, a derivative thereof, or a salt of either, and the preparation of a mammalian cell suspension for the prevention of pulmonary embolism formation when administering mammalian cells intravenously, said suspension containing as an effective component thereof: mammalian cells; and trehalose, a derivative thereof, or a salt of either. In addition to mammalian stem cells, islet cells, dendritic cells, natural killer cells, alpha-beta T cells, gamma-delta T cells, and cytotoxic T lymphocytes, etc., can be used as the mammalian cells. Mammalian mesenchymal stem cells and mammalian pluripotent stem cells are suitable examples of mammalian stem cells. |
priorityDate | 2012-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.